Amedisys Inc (AMED) Social Stream
Amedisys Inc (AMED) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering AMED.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 13 | $265 | $195 | $240.92 | $150.58 | 59.99% |
The Trend in the Analyst Price Target
Over the past 16 months, AMED's average price target has gone up $28.46.
Over the past 16 months, AMED's average upside potential has been 21.78%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-20 | 13 | 265 | 195 | 240.92 | 167.67 | 43.69% |
| 2021-09-19 | 13 | 265 | 195 | 240.92 | 171.13 | 40.78% |
| 2021-09-18 | 13 | 265 | 195 | 240.92 | 171.13 | 40.78% |
| 2021-09-11 | 12 | 265 | 220 | 244.75 | 180.25 | 35.78% |
| 2021-09-04 | 12 | 265 | 220 | 244.75 | 183.17 | 33.62% |
| 2021-08-28 | 12 | 265 | 220 | 244.75 | 177.56 | 37.84% |
| 2021-08-14 | 12 | 320 | 220 | 251.17 | 180.62 | 39.06% |
| 2021-08-07 | 12 | 340 | 220 | 288.25 | 191.34 | 50.65% |
| 2021-08-05 | 12 | 350 | 310 | 330.25 | 200.13 | 65.02% |
| 2021-08-01 | 12 | 350 | 310 | 330.25 | 260.62 | 26.72% |
| 2021-07-24 | 12 | 350 | 310 | 330.25 | 264.00 | 25.09% |
| 2021-07-17 | 12 | 350 | 310 | 330.25 | 258.44 | 27.79% |
| 2021-07-10 | 12 | 350 | 310 | 330.25 | 269.93 | 22.35% |
| 2021-07-03 | 12 | 350 | 310 | 330.25 | 264.66 | 24.78% |
| 2021-06-26 | 12 | 350 | 310 | 331.92 | 249.72 | 32.92% |
| 2021-06-13 | 12 | 350 | 310 | 331.92 | 252.93 | 31.23% |
| 2021-06-05 | 12 | 350 | 310 | 331.92 | 255.61 | 29.85% |
| 2021-05-22 | 12 | 350 | 310 | 331.92 | 258.96 | 28.17% |
| 2021-05-15 | 12 | 350 | 310 | 331.92 | 256.97 | 29.17% |
| 2021-05-08 | 12 | 350 | 310 | 331.92 | 260.13 | 27.6% |
| 2021-04-25 | 12 | 340 | 300 | 327.33 | 284.57 | 15.03% |
| 2021-04-17 | 12 | 340 | 300 | 327.33 | 282.96 | 15.68% |
| 2021-04-10 | 12 | 340 | 300 | 327.33 | 283.09 | 15.63% |
| 2021-04-03 | 12 | 340 | 300 | 329.00 | 269.46 | 22.1% |
| 2021-03-20 | 13 | 340 | 261 | 323.77 | 269.00 | 20.36% |
| 2021-03-13 | 13 | 340 | 261 | 323.77 | 266.30 | 21.58% |
| 2021-03-06 | 13 | 340 | 261 | 323.77 | 241.25 | 34.21% |
| 2021-02-27 | 13 | 340 | 261 | 323.77 | 253.64 | 27.65% |
| 2021-02-20 | 13 | 340 | 261 | 316.69 | 292.48 | 8.28% |
| 2021-02-13 | 13 | 340 | 261 | 316.69 | 308.82 | 2.55% |
| 2021-02-06 | 14 | 340 | 261 | 313.00 | 298.83 | 4.74% |
| 2021-01-30 | 14 | 340 | 261 | 313.00 | 287.31 | 8.94% |
| 2021-01-23 | 14 | 340 | 261 | 309.43 | 313.54 | -1.31% |
| 2021-01-16 | 14 | 340 | 261 | 309.43 | 293.89 | 5.29% |
| 2021-01-09 | 14 | 340 | 261 | 302.14 | 307.07 | -1.61% |
| 2021-01-02 | 14 | 310 | 261 | 283.64 | 293.33 | -3.3% |
| 2020-12-26 | 14 | 310 | 261 | 283.64 | 292.35 | -2.98% |
| 2020-12-19 | 14 | 300 | 261 | 280.79 | 289.80 | -3.11% |
| 2020-12-09 | 14 | 300 | 261 | 280.79 | 262.40 | 7.01% |
| 2020-12-07 | 14 | 300 | 261 | 280.79 | 255.74 | 9.8% |
| 2020-11-15 | 14 | 300 | 261 | 280.79 | 243.43 | 15.35% |
| 2020-11-02 | 14 | 300 | 261 | 280.79 | 254.38 | 10.38% |
| 2020-10-29 | 14 | 300 | 250 | 279.43 | 250.87 | 11.38% |
| 2020-09-17 | 14 | 290 | 245 | 258.29 | NA | NA% |
| 2020-09-09 | 14 | 290 | 245 | 257.57 | NA | NA% |
| 2020-09-01 | 14 | 290 | 235 | 256.86 | NA | NA% |
| 2020-08-19 | 14 | 290 | 235 | 255.43 | NA | NA% |
| 2020-07-31 | 13 | 270 | 235 | 252.23 | NA | NA% |
| 2020-07-22 | 13 | 260 | 190 | 218.00 | NA | NA% |
| 2020-07-16 | 13 | 260 | 190 | 218.00 | NA | NA% |
| 2020-07-11 | 13 | 260 | 190 | 214.38 | NA | NA% |
| 2020-07-01 | 13 | 240 | 190 | 212.85 | NA | NA% |
| 2020-06-17 | 13 | 240 | 190 | 212.85 | NA | NA% |
| 2020-06-07 | 13 | 240 | 190 | 212.46 | NA | NA% |
AMED Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.62 | 3 | 7 | 5 | 0 | 0 | 16 |
The Trend in the Broker Recommendations
Over the past 30 days, AMED's average broker recommendation rating worsened by 0.18.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- The average analyst price target of AMED is higher than 95.12% of all US stocks.
- AMED has a higher number of analysts covering the stock than 89.96% of Healthcare stocks.
- The upside potential (average analyst target price relative to current price) of AMED is greater than 84.64% of stocks in the mid market cap category.
- Amedisys Inc's variance in analysts' estimates is lower than 60.33% of Healthcare stocks.
Stocks similar to Amedisys Inc in the Healthcare industry regarding analyst recommendations and price targets are LHCG, DGX and THC.
What is the outlook for AMED? Use POWR Ratings for clearer insight into price direction.